T-cell attacking cancer tumour
Oncology

At GSK Oncology we are passionate about maximising patient survival through the development and discovery of novel treatments.

Our products

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441.

© 2021 GSK group of companies or its licensor.
Trademarks are owned by or licensed to the GSK group of companies.

March 2022 | PM-GB-ON-WCNT-210001 (V1.0)